e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchospasm secondary to nebulised antibiotics in bronchiectasis
R. Njafuh (SOUTHSEA, United Kingdom)
Source:
International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Session:
Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Session type:
Thematic Poster
Number:
4069
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Njafuh (SOUTHSEA, United Kingdom). Bronchospasm secondary to nebulised antibiotics in bronchiectasis. 4069
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016
Distribution of nebulised gentamicin in patients with bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Antibiotic treatment strategies in adults with bronchiectasis
Source: Eur Respir Mon 2011; 52: 211-222
Year: 2011
Exacerbations and inhaled corticosteroids in bronchiectasis patients
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002
Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018
Year: 2019
Τhe administration of nebulised racemic epinephrine in asthma exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004
Inhaled antibiotics in chronic airway infections
Source: Eur Respir Monogr 2017; 75: 57-79
Year: 2017
Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004
Oral antibiotics vs placebo for exacerbations of paediatric bronchiectasis
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019
Efficacy of nebulised adrenaline and salbutamol on mild to moderate bronchiolitis
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003
Inhaled antimicrobials
Source: ERS webinar 2020: Inhaled antimicrobials
Year: 2020
The clinical impact of nebulised antibiotics in adults with bronchiectasis and chronic pseudomonas aeruginosa
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Co-dispensing of inhaled corticosteroids and antibiotics
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004
The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept